KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Acquisitions (2016 - 2024)

Globus Medical's Acquisitions history spans 12 years, with the latest figure at $100000.0 for Q3 2024.

  • For Q3 2024, Acquisitions fell 99.97% year-over-year to $100000.0; the TTM value through Dec 2025 reached $100000.0, down 99.43%, while the annual FY2025 figure was $252.5 million, 1332.07% up from the prior year.
  • Acquisitions reached $100000.0 in Q3 2024 per GMED's latest filing, down from $4.9 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $293.4 million in Q3 2023 to a low of $100000.0 in Q3 2024.
  • Average Acquisitions over 4 years is $35.7 million, with a median of $3.8 million recorded in 2023.
  • Peak YoY movement for Acquisitions: soared 544.05% in 2020, then plummeted 99.97% in 2024.
  • A 4-year view of Acquisitions shows it stood at $1.5 million in 2020, then soared by 1928.15% to $30.3 million in 2022, then soared by 869.48% to $293.4 million in 2023, then tumbled by 99.97% to $100000.0 in 2024.
  • Per Business Quant, the three most recent readings for GMED's Acquisitions are $100000.0 (Q3 2024), $4.9 million (Q2 2024), and $12.6 million (Q1 2024).